N-Benzylated benzimidazol-2-one derivatives: Activators of large-conductance Ca2+-dependent K+ channels

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 14, 1996, Pages 1641-1646

  Meanwell, Nicholas A ^a   Sit, Sing Yuen ^a   Gao, Jinnian ^a   Boissard, Christopher G ^a   Lum Ragan, Janet ^a   Dworetzky, Steven I ^a   Gribkoff, Valentin K ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 CHLORO 2 HYDROXYPHENYL) 5 TRIFLUOROMETHYL 2 BENZIMIDAZOLONE; BENZIMIDAZOLE DERIVATIVE; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG SYNTHESIS; ELECTROPHYSIOLOGY; GENE EXPRESSION; NONHUMAN; OOCYTE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; XENOPUS;

ANIMALIA; XENOPUS LAEVIS;

EID: 0030598665     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00296-X     Document Type: Article

References (32)

1. 1. Department of Chemistry.
2. 2. Department of Central Nervous System Drug Discovery.
3. 3. Longman, S. D.; Hamilton, T. C. Med. Res. Rev. 1992, 12, 73.
4. 4. Atwal, K. Med. Res. Rev. 1992, 12, 569.
5. 5. Gopalakrishnan, M.; Janis, R.; Triggle, D. Drug Dev. Res. 1993, 28, 95.
6. 6. Primeau, J.; Butera, J. Curr. Pharm. Des. 1995, 1, 391.
7. 7. McKay, M. C.; Dworetzky, S. I.; Meanwell, N. A.; Olesen, S.-P.; Reinhart, P. H.; Levitan, I. B.; Adelman, J. P.; Gribkoff, V. K. J. Neurophysiol. 1994, 71, 1873.
8. 8. Olesen, S.-P. Exp. Opin. Invest. Drugs 1994, 3, 1181.
9. 9. Olesen, S.-P.; Munch, E.; Moldt, P.; Drejer, J. Eur. J. Pharmacol. 1994, 251, 53.
10. 10. Olesen, S.-P.; Munch, E.; Wätjen, F.; Drejer, J. Neuro Report 1994, 5, 1001.
11. 11. Latorre, R.; Oberhauser, A.; Labarca, P.; Alvarez, O. Ann. Rev. Physiol. 1989, 51, 385.
12. 12. Sah, P. Trends Neurosci. 1996, 19, 150.
13. 13. Xu, X.; Tsai, T. D.; Wang, J.; Lee, E. W.; Lee, K. S. J. Pharm. Exp. Ther. 1994, 271, 362.
14. 14. Edwards, G.; Niederste-Hollenberg, A.; Schneider, J.; Noack, Th.; Weston, A. H. Br. J. Pharmacol. 1994, 113, 1538.
15. 15. Lee, K.; Rowe, I. C. M.; Ashford, M. L. J. Eur. J. Pharmacol. 1995, 280, 215.
16. 16. (a) Popp, F. D. Adv. Het. Chem. 1975 18, 1.;
17. (b) Di Carlo, F. J.; Lindwall, H. G. J. Org. Chem. 1945, 67, 199.;
18. (c) Snieckus, V. A.; Onouchi, T.; Boekelheide, V. J. Org. Chem. 1972, 37, 2845.
19. 17. Shioiri, Y.; Ninomiya, K.; Yamada, S. J. Am. Chem. Soc. 1972, 94, 6203.
20. 18. (a) Hershenson, F. M.; Bauer, L.; King, K. F. J. Org. Chem. 1968, 33, 2543;
21. (b) Harrison, D.; Smith, A. C. B. J. Chem. Soc. 1959, 3157.
22. 19. Meanwell, N. A.; Sit, S. Y.; Gao, J.; Wong, H. S.; Balasubramanian, N.; St. Laurent, D.; Gao, Q. J. Org. Chem. 1995, 60, 1565.
23. 20. Bellamy, F. D.; Ou, K. Tetrahedron. Lett. 1984, 25, 839.
24. 21. (a) Staab, H. A. Angew. Chem. Int. Edn. Engl. 1962, 1, 351;
25. (b) Wright, W. B. J. Het. Chem. 1965, 2, 41.
26. 22. Kametani, T.; Sota, K.; Shio, M. J. Het. Chem. 1970, 7, 807.
27. 23. McComie, J. F. W.; Watts, M. L.; West, D. E. Tetrahedron 1968, 24, 2289.
28. 24. Gates, M.; Tschudi, G. J. Am. Chem. Soc. 1956, 78, 1380.
29. 13C, and mass spectral data were consistent with the assigned structures. Satisfactory combustion analysis data, within ±0.4 of the theoretical value, was obtained for all compounds.
30. 26. Butler, A.; Tsunoda, S.; McCobb, D. P.; Wei, A.; Salkoff, L. Science 1993, 261, 221.
31. 27. Dworetzky, S. I.; Trojnacki, J. T.; Gribkoff, V. K. Mol. Brain Res. 1994, 27, 189.
32. 28. Gribkoff, V. K.; Lum-Ragan, J. T.; Boissard, C. G.; Post-Munson, D. J.; Meanwell, N. A.; Starrett, J. E., Jr., Kozlowski, E. S.; Romine, J. L.; Trojnacki, J. T.; McKay, M. C.; Zhong, J.; Dworetzky, S. I. Mol. Pharmacol., in press.